The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
about
The in-depth evaluation of suspected mitochondrial diseaseMitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.Coenzyme q10 therapyOxidative stress, mitochondrial damage and neurodegenerative diseasesTAT opens the door.Reactive oxygen species in the regulation of synaptic plasticity and memory.Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.A modern approach to the treatment of mitochondrial diseaseWhy are there no proven therapies for genetic mitochondrial diseases?Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant miceSymptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression.Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes.How can we treat mitochondrial encephalomyopathies? Approaches to therapyMitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes.Design and implementation of the first randomized controlled trial of coenzyme CoQ₁₀ in children with primary mitochondrial diseasesMitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course.Effect of mitochondrial dysfunction and oxidative stress on endogenous levels of coenzyme Q(10) in human cells.Mitochondrial myopathy presenting as fibromyalgia: a case report.Metabolic myopathy presenting with polyarteritis nodosa: a case report.A randomized trial of coenzyme Q10 in mitochondrial disorders.Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.Mitochondrial disease patient motivations and barriers to participate in clinical trials.
P2860
Q33608204-D7245787-0A6B-410E-BFA0-57002BCF23F5Q33668501-7A564874-EA8A-4FC6-BCDC-01C37E16FE9AQ33956936-A5461D67-B131-4FB9-8C3A-8C5A53470F6BQ34094532-ACC9AF7B-7288-4E37-942C-93A947FE47B4Q34339371-9D73FF41-A46A-40AF-B6BE-9E4973E92B4BQ34805998-1BE716D0-235D-45EE-B03B-34BC32D7D458Q34989407-29236080-7115-4C61-8063-24EA267EC479Q35011397-055B6132-41A2-4C54-9E98-0FF374BDCF6FQ35162928-AADC5676-7712-486A-81A7-BE593C395062Q36088905-25FC997B-F5CF-45EA-8DCD-32FEE7AD33ADQ36515986-20CFDEF2-3BBA-4ADC-82A6-8AF3D85515CBQ36744667-73514D45-73D0-43F8-B00F-B3273D32CC09Q37210464-B650FF72-D313-4933-905E-962F3D76692FQ37299591-A3A6BA6D-0C3B-4D77-BBAC-D6BB9B7E6709Q37329530-778F830A-CBB9-4CF6-8DA5-5AA55455B1CBQ37653023-0693E354-8669-4717-AF95-7141E01DBE64Q37684926-7A924819-B414-4411-8C80-E84789E2B8D6Q37970121-7E1CEF56-E8BA-4FA4-A4C4-B7F87A60E3B0Q39594821-4EFE0680-2818-4933-87A7-111871B27AB6Q42608494-096AF16C-B1B0-4C08-9F2E-4D228960256DQ42852551-7C236B02-6D1C-49FF-8298-CB0287230C60Q42872025-F4152780-7D74-423A-8C66-47C72853A43EQ47988632-D0B6E02B-2067-41EB-9DA7-0337D19FB98AQ52360003-A6828B5A-7153-417A-8947-D307165E6E03Q55313136-B5D37F04-F02F-4BBE-9396-7EE306CCE6CB
P2860
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@ast
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@en
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@nl
type
label
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@ast
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@en
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@nl
prefLabel
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@ast
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@en
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@nl
P1433
P1476
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
@en
P2093
Richard H Haas
P304
P356
10.1016/J.MITO.2007.03.008
P478
P577
2007-03-30T00:00:00Z